
David M. Jablons, M.D.
Professor and Chief, Thoracic Surgery
Program Leader, Thoracic Oncology Program
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by UCSF thoracic surgeons David M. Jablons, M.D. and Michael Mann, M.D. (pictured left) demonstrated that a molecular test can better predict the likelihood of death from early-stage lung cancer than conventional methods.
A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.
Lung cancer is the leading
cause of cancer death worldwide and the Thoracic Oncology Program
is poised to conquer it. UCSF provides state-of-the-art care to
patients with lung cancer, mesothelioma, esophageal cancer, sarcoma
and cancer that has metastasized to the chest. The program is led
by David M. Jablons, M.D., Chief of
the Section of General Thoracic Surgery and Program Leader of the
Thoracic Oncology Program. Patients receive treatment from a
dedicated multidisciplinary team of specialists. At
UCSF, one of the world's leading biomedical research centers,
patients also have access to clinical trials for promising
new drugs.